Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utilizing Contrast-enhanced Ultrasound (CEUS) to Assess Critically Hypo Perfused Spinal Cord Tissue After Injury
NCT04056988Phase 4Completed
- Sponsor
- University of Washington
- Start
- Jul 2018
- Primary completion
- Nov 2023
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of perflutren lipid microspheres in spinal cord injury (SCI), sponsored by University of Washington. Started Jul 2018; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT04056988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056988.